Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Phaxiam Therapeutics S.A.
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
March 11, 2024
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
February 20, 2024
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
January 18, 2024
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
November 14, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
October 24, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation
October 23, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Tickers
PHXM
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
October 09, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Receives Compliance Notice from Nasdaq
October 04, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
October 03, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Provides Business and Financial Update For the First Half of 2023
September 21, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target
September 19, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Therapeutics announces the completion of its reverse share split
September 18, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
September 05, 2023
From
Phaxiam Therapeutics S.A.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.